Sign in

CIK 0001604464

  • Non-accelerated filer
  • Smaller reporting company

Atara Biotherapeutics, Inc.

Sign in to watch
Ticker
ATRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460920988
Phone
+1 805-623-4211
Business address
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
Open-market buys, last 90 days
$999,994
in 1 filing
Open-market sales, last 90 days
$39,368
in 1 filing

Net +$960,625. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Cherry Brian N +$1000K Director 1 filing
  2. Nguyen AnhCo −$39K President and CEO sold 5% of stake

Reading 3 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-02-15 Clark Mitchall G. EVP & Chief R & QA Officer Exercise or conversion +7,211 152,720
2017-02-15 Clark Mitchall G. EVP & Chief R & QA Officer Exercise or conversion · Restricted Stock Unites −7,211 33,654
2017-02-15 Haqq Christopher EVP, R&D & Chief Scientific Of Exercise or conversion +829 400,459
2017-02-15 Haqq Christopher EVP, R&D & Chief Scientific Of Sale −7,604 $15.49 $118K 392,855
2017-02-15 Haqq Christopher EVP, R&D & Chief Scientific Of Exercise or conversion · Restricted Stock Units −829 3,040
2017-02-15 Ciechanover Isaac E. Chief Executive Officer Exercise or conversion +5,907 725,951
2017-02-15 Ciechanover Isaac E. Chief Executive Officer Sale −2,400 $15.54 $37K 351,378
2017-02-15 Ciechanover Isaac E. Chief Executive Officer Exercise or conversion · Restricted Stock Units −5,907 21,662
2017-02-14 Soffer Gad EVP & Chief Strategy Officer Sale −7,000 $15.22 $107K 262,538
2017-02-10 Soffer Gad EVP & Chief Strategy Officer Sale −5,874 $15.42 $91K 269,938
2017-02-10 Soffer Gad EVP & Chief Strategy Officer Sale −400 $16.13 $6K 269,538
2017-02-09 Haqq Christopher EVP, R&D & Chief Scientific Of Sale −13,975 $15.46 $216K 399,630
2017-02-09 Turner Heather D EVP, General Counsel & Sec. Sale −11,582 $15.70 $182K 86,775
2017-02-09 Turner Heather D EVP, General Counsel & Sec. Sale −633 $16.16 $10K 86,142
2017-02-06 Haqq Christopher EVP, R&D & Chief Scientific Of Grant or award +49,500 413,605
2017-02-06 MCGRATH JOHN EVP & Chief Financial Officer Grant or award +49,500 149,326
2017-02-06 Soffer Gad EVP & Chief Strategy Officer Grant or award +45,000 275,812
2017-02-06 Turner Heather D EVP, General Counsel & Sec. Grant or award +49,500 98,357
2017-02-06 Ciechanover Isaac E. Chief Executive Officer Grant or award +165,000 720,044
2017-02-06 Clark Mitchall G. EVP & Chief R & QA Officer Grant or award +49,500 144,687

Page 47 of 71 · 1,403 trades